Plasma concentrations of timiperone and its reduced metabolite in the patients on timiperone.
Plasma levels of timiperone (TIM) and reduced timiperone (RTIM) were determined in 10 schizophrenic patients who were treated with TIM. Activities of ketone reductase in red blood cells (RBC) were assayed using TIM and haloperidol (HAL) as substrates. Plasma levels of TIM and RTIM ranged from 3.2 ng/mL to 9.5 ng/mL and from 1.7 ng/mL to 7.6 ng/mL, respectively, and approximately four-fold inter-individual variations in RTIM/TIM (0.37-1.43, 0.67 +/- 0.25) were observed. There were significant and positive correlations between plasma levels of TIM or RTIM with the daily doses of TIM (mg/kg body weight); TIM (ng/mL)= 19.5 x daily dose of TIM (mg/kg) + 1.3, r = 0.79, n = 18, P < 0.01; RTIM (ng/mL) = 13.1 x daily dose of TIM (mg/kg) + 0.7, r = 0.73, n = 18, P < 0.001). Given 0.3 mg/kg of TIM, a plasma level of TIM as 7.15 ng/mL was predicted, which is approximately 60% that of HAL. The activity of TIM reductase in RBC was determined as approximately 70% of HAL reductase in RBC, although the correlation between the activities of TIM reductase and HAL reductase in RBC was high (r = 0.98, n = 10, P < 0.001).
Shimoda
K
K
Department of Psychiatry, Shiga University of Medical Science, Otsu, Japan. shimoda@belle.shiga-med.ac.jp
Someya
T
T
Morita
S
S
Hirokane
G
G
Yokono
A
A
Shibasaki
M
M
Takahashi
S
S
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000737:chemistry / Q000493:pharmacokinetics*; D002090:Butyrophenones / Q000737:chemistry / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology; D013329:Structure-Activity Relationship
D014150:Antipsychotic Agents; D002090:Butyrophenones; C024159:timiperone